Cargando…

Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system

PURPOSE: To assess the agreement between patient‐reported and health care provider‐reported medical information in inflammatory bowel disease (IBD). METHODS: This multicentre, prospective, event monitoring study enrolled adult Crohn's disease (CD) and ulcerative colitis (UC) patients treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Pepijn W. A., West, Rachel L., Russel, Maurice G. V. M., Jansen, Jeroen M., Kosse, Leanne J., Jessurun, Naomi T., Römkens, Tessa E. H., Hoentjen, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983909/ https://www.ncbi.nlm.nih.gov/pubmed/33219593 http://dx.doi.org/10.1002/pds.5175

Ejemplares similares

Discrepancy between patient‐ and healthcare provider‐reported adverse drug reactions in inflammatory bowel disease patients on biological therapy
por: Thomas, Pepijn W. A., et al.
Publicado: (2021)

Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry
por: Giraud, Eline L., et al.
Publicado: (2021)

De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
por: Thomas, Pepijn W. A., et al.
Publicado: (2022)

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study
por: Thomas, Pepijn W A, et al.
Publicado: (2022)

Long-term effectiveness and safety of ustekinumab in Crohn’s disease: a prospective cohort study
por: Thomas, Pepijn W.A., et al.
Publicado: (2022)

Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis
por: Savelkoul, Edo H J, et al.
Publicado: (2022)

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
por: Jansen, Fenna M., et al.
Publicado: (2023)

Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry Study
por: Simsek, Melek, et al.
Publicado: (2023)

Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
por: Derikx, Lauranne A A P, et al.
Publicado: (2020)

Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2021)

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study
por: Asscher, Vera E. R., et al.
Publicado: (2020)

Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis
por: Brown, Joshua D, et al.
Publicado: (2021)

Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
por: De Jong, Michiel E, et al.
Publicado: (2019)

A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category
por: Zhang, Ming M., et al.
Publicado: (2023)

Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn’s Disease Patients: A Case Report and Review of the Literature
por: Thomas, Pepijn W A, et al.
Publicado: (2020)

Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2023)

vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real‐world use
por: Caster, Ola, et al.
Publicado: (2017)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018)

Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed
por: Loveikyte, Roberta, et al.
Publicado: (2022)

Lower gastrointestinal bleeding in a patient receiving sevelamer: Case report
por: Schoot, Tessa S, et al.
Publicado: (2021)

Effectiveness of Mindfulness-Based Cognitive Therapy in reducing psychological distress and improving sleep in patients with Inflammatory Bowel Disease: study protocol for a multicentre randomised controlled trial (MindIBD).
por: ter Avest, Milou M, et al.
Publicado: (2023)

Hepatic disorders associated with the use of Ivermectin for SARS-CoV-2 infection in adults: a pharmacovigilance study in VigiBase
por: Oscanoa, Teodoro J., et al.
Publicado: (2022)

Dictionary of pharmacovigilance /
por: Alghabban, Amer
Publicado: (2004)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)

Challenges in pharmacovigilance
por: Dikshit, R. K.
Publicado: (2010)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Pharmacovigilance inspections
por: Fitzgerald, Patricia
Publicado: (2008)

Pharmacovigilance in Asia
por: Biswas, Pipasha
Publicado: (2013)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Pharmacovigilance in oncology
por: Baldo, Paolo, et al.
Publicado: (2018)

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study
por: Sivridaş, Merve, et al.
Publicado: (2023)

International Society of Pharmacovigilance monitors vaccine safety
Publicado: (2022)

A fast and reliable method for monitoring of prophage‐activating chemicals
por: Xu, Juan, et al.
Publicado: (2018)

Inter-Rater Reliability of Provider Interpretations of Irritable Bowel Syndrome Food and Symptom Journals
por: Zia, Jasmine, et al.
Publicado: (2017)

Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor
por: van Lint, Jette A., et al.
Publicado: (2023)

A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

A Pilot Study to Assess the Reliability of Digital Image-Based PASI Scores Across Patient Skin Tones and Provider Training Levels
por: Wu, David, et al.
Publicado: (2022)

Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
por: Volkers, Adriaan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rnsr3flh0s0h6pckb31l9pt94a